| Literature DB >> 22013538 |
B A Rogers1, A Sternheim, D Backstein, O Safir, A E Gross.
Abstract
As the indications for total hip arthroplasty increase, the prevalence of extensive proximal femoral bone loss will increase as a consequence of massive osteolysis, stress shielding and multiple revisions. Proximal femoral bone stock deficiency provides a major challenge for revision hip arthroplasty and is likely to account for a significant future caseload. Various surgical techniques have been advocated included impaction allografting, distal press-fit fixation and massive endoprosthetic reconstruction. This review article provides a systematic review of the current literature to assess the outcome of revision hip arthroplasty using allograft to reconstruction massive proximal femoral bone loss.Entities:
Year: 2011 PMID: 22013538 PMCID: PMC3195279 DOI: 10.4061/2011/257572
Source DB: PubMed Journal: Adv Orthop ISSN: 2090-3464
Figure 1(a) Prosthesis cemented into allograft. (b) Trochanteric slide approach to hip, with lateral cortex osteotomy to facilitate removal of in situ femoral component. (c) Allograft-prosthesis composite inserted into host, with junctional step cut. (d) Remnants of host proximal femur are fixed around allograft, especially at the allograft-host junction, and the greater trochanter reattached.
Figure 2A radiograph 17 years after proximal femoral allograft (reprinted from Safir et al. [19]).
Sixteen studies using allograft prosthetic composite in the treatment of proximal femoral bone loss, number of patients per study, primary diagnosis, and mean followup.
| Study |
| Primary diagnosis | Mean followup (yrs) | |
|---|---|---|---|---|
| 1 | Chandler et al. [ | 30 | Aseptic | 2 |
| 2 | Langlais et al. [ | 21 | Tumor | 6 |
| 3 | Haddad et al. [ | 55 | Tumor, Aseptic, Septic revision | 8.8 |
| 4 | Zehr et al. [ | 14 | Tumor | 10 |
| 5 | Zmolek and Dorr [ | 15 | Aseptic failure | 2 |
| 6 | Safir et al. [ | 50 | Septic, aseptic | 16.2 |
| 7 | Vastel et al. [ | 44 | Aseptic failure | 7.1 |
| 8 | Babis et al. [ | 72 | Aseptic | 12 |
| 9 | Lee et al. [ | 15 | Aseptic, septic loosening | 4.2 |
| 10 | Roque et al. [ | 73 | Tumor | 6.7 |
| 11 | Biau et al. [ | 32 | Tumor | 5.6 |
| 12 | Donati et al. [ | 22 | Tumor | 4.8 |
| 13 | Farid et al. [ | 20 | Tumor | 6.3 |
| 14 | Graham and Stockley [ | 25 | Aseptic, septic loosening | 4.5 |
| 15 | Muscolo et al. [ | 37 | Tumor | 7.5 |
| 16 | J. W. Wang and C. J. Wang [ | 15 | Aseptic, septic loosening | 7.6 |
Surgical techniques used including approach, the type of femoral osteotomy performed at the host bone-allograft junction, and whether the host proximal femur was resected or split and used as an onlay graft. NR: not reported. Study numbers correlate with Table 1.
| Study |
| Surgical approach | Femoral osteotomy | Host proximal femur |
|---|---|---|---|---|
| 1 | 30 | Trochanteric slide | Step cut (7) transverse (23) | NR |
| 2 | 21 | Complete resection | Step cut | Resected |
| 3 | 55 | NR | Transverse (28), step cut (12) | Resected |
| 4 | 14 | Complete resection | NR | Resected |
| 5 | 15 | Posterolateral (9), trochanteric Slide (2) | Oblique | Resected |
| 6 | 50 | Trochanteric slide | Step cut | Split and onlay |
| 7 | 44 | Transtrochanteric | Transverse | Split and onlay |
| 8 | 72 | Hardinge (44), posterior (11), transtrochanteric (17) | Step cut (62), telescoping (10) | Split and onlay |
| 9 | 15 | Transtrochanteric | Transverse (9), step cut (6) | NR |
| 10 | 73 | Complete resection | NR | Resected |
| 11 | 32 | Trochanteric slide (12), resection (20) | Transverse | Resected |
| 12 | 22 | Complete resection | Transverse | Resected |
| 13 | 20 | NR | NR | Resected |
| 14 | 25 | Trochanteric slide | Step cut | Split and onlay |
| 15 | 37 | Posterolateral (28), transtrochanteric (10) | Transverse | Resected |
| 16 | 15 | Transtrochanteric | Transverse | Split and onlay |
Table showing methods of implantation of prosthesis into allograft to form the allograft prosthesis composite (APC) and methods for securing APC to distal host femur. NR: not reported. Study numbers correlate with Table 1.
| Study | Allograft-prosthesis fixation | APC-host bone fixation |
|---|---|---|
| 1 | Cemented | Uncemented |
| 2 | Cemented | Cemented |
| 3 | Cemented | Cemented |
| 4 | Cemented (16), uncemented (2) | Cemented(14), Uncemented(2), + plating(2) |
| 5 | Uncemented | Uncemented + plating |
| 6 | Cemented | Uncemented |
| 7 | Cemented | Cemented |
| 8 | Cemented | Uncemented (44), cemented (22) |
| 9 | Cemented | Uncemented (12), cemented (3) |
| 10 | NR | NR |
| 11 | Cemented | Cemented |
| 12 | Cemented | Uncemented |
| 13 | Cemented | Varied |
| 14 | Cemented | Uncemented |
| 15 | Cemented | Uncemented + plating |
| 16 | Cemented | Uncemented (13), cemented (2), + plating |
Table showing complications of prosthesis into allograft to form the allograft prosthesis composite (APC) and methods for securing APC to distal host femur. The total cohort included 498 patients with a mean follow up of 8.1 years (range 2 to 16.2 years). The pooled success rate was 81% (95% CI 77%–86%). Success rate: APC not revised. NR: not reported. Study numbers correlate with Table 1.
| Study |
| Failed constructs | Success rate | Infection | Dislocation | Aseptic loosening or fracture |
|---|---|---|---|---|---|---|
| 1 | 30 | 3 | 90% | 1 (3.3%) | 5 (16.7%) | 4 (13.3%) |
| 2 | 21 | 2 | 82% | 0 | 0 | 6 (28.6%) |
| 3 | 55 | 6 | 85% | 2 (3.6%) | 4 (7.3%) | 5 (9.1%) |
| 4 | 14 | 4 | 78% | 3 (21.4%) | NR | 1 (7.1%) |
| 5 | 15 | 3 | 73% | 1 (6.7%) | 6 (40%) | 2 (13.3%) |
| 6 | 50 | 8 | 84% | 2 (4%) | 4 (8%) | 7 (14.0%) |
| 7 | 44 | 4 | 91% | 1 (2.3%) | 6 (13.6%) | 3 (6.8%) |
| 8 | 72 | 19 | 66% | 5 (6.9%) | 8 (11.1) | 14 Loosening (4), resorption (3), nonunion (2), fracture (4), stem fracture (1) |
| 9 | 15 | 2 | 87% | 1 (6.7%) | 1 (6.7%) | 1 (6.7%) |
| 10 | 73 | 13 | 82% | 8 (10.9%) | 0 | 11 (15.1%) |
| 11 | 32 | 9 | 72% | 4 (12.5%) | NR | 5 (15.6%) |
| 12 | 22 | 2 | 91% | 1 (4.5%) | NR | 1 (4.6%) |
| 13 | 20 | 1 | 95% | 1 (5.0%) | 2 (10%) | 0 |
| 14 | 25 | 2 | 92% | 1 (4.0%) | NR | 2 (8.0%) |
| 15 | 37 | 10 | 73% | 3 (8.1%) | NR | 7 (18.9%) |
| 16 | 15 | 5 | 67% | 3 (20%) | 1 (6.7) | 4 (20.7%) |